Fig 1: The methylation rates of miR-23’s promoter in MM. (A) the selected promoter region of miR-23 and island in the selected regions were shown. (B) the methylation rates of miR-23’s promoter region in MM clinical specimens or the primary B cells. (C–F) the co-relationship between miR-23 with the methylation rates of miR-23’s promoter region in different MM specimens. (G–J) the co-relationship between uPA/PLAU with the methylation rates of miR-23’s promoter region in different MM specimens. *P < 0.05.
Fig 2: miR-324-5p overexpression suppressed matrix metalloproteinase 9 (MMP-9) and urokinase-type plasminogen activator (uPA) system. In SW620 (A) and SW480 (B) cells, the proinvasion factors MMP-9, uPA, and uPA receptor (uPAR) were tested by Western blotting. **p < 0.01 versus NC group.
Fig 3: Expression of miR-23 and uPA in MM. (A) The expression level of uPA in MM specimensat different stages or primary B cells. (B) The expression level of 7 miRNA molecules (miR-23, miR-193a, miR-5692a, miR-3606-5p, miR-645, miR-4363 or miR-3190-59) potentially targeting to the 3’UTR of uPA was examined in the MM clinical specimens. (C) The expression level of miR-23 in MM specimens at different stages or primary B cells. (D) The targeting site of miR-23 at 3’UTR of uPA or mutated sequences. (E) The expression of uPA, miR-23, or the promoter region of miR-23 in MM cells. (F, G) The effects of miR-23 on uPA protein level in PDC-7 and PDC-8. (H–K) The association between miR-23 and uPA in MM specimens at different stages. *P<0.05.
Fig 4: Effects of exogenously introduced PATZ1 in ATC cell lines(A) The expression of PATZ1, uPA, and MMPs in ATC cell lines transfected with pcDNA3-FLAG (vector) or pcDNA3-FLAG-PATZ1 (PATZ1). A representative western blot is shown. The nuclear expression of exogenously introduced protein was confirmed by using Flag M2 antibody. SP1 and ß-actin were used as internal loading control for nuclear extract and whole cell lysate, respectively. (B) Cell proliferation assay for ACT-1 cells transfected with pcDNA3-FLAG or pcDNA3-FLAG-PATZ1. The number of cells was counted every 24 h until 96 h after seeding the cells. *p < 0.05. (C) Cell proliferation assay for FRO cells transfected with pcDNA3-FLAG or pcDNA3-FLAG-PATZ1. *p < 0.05. (D) Chamber migration assay for ATC cell lines transfected with pcDNA3-FLAG or pcDNA3-FLAG-PATZ1. Representative images of migrating cells stained with crystal violet at 24 h (left panel, scale bar = 200 µm). The number of migrated cells is shown in the bar chart (right panel). (E) Chamber-invasion assay for ATC cell lines transfected with pcDNA3-FLAG or pcDNA3-FLAG-PATZ1. The cells that invaded through the transwell chamber coated with collagen type IV were counted as described in the Materials and Methods. The absorbance values are shown in the bar chart.
Fig 5: Effects of PATZ1 knockdown on cell proliferation, migration, and invasion in Nthy-ori 3-1 cells(A) Cell proliferation assay for Nthy-ori 3-1 cells transfected with control siRNA (si-control) or siRNA targeting PATZ1 (si-PATZ1). The number of cells was counted every 24 h until 96 h after seeding the cells. The number of cells is shown in the bar chart. *p < 0.05. (B) Scratch wound assay for Nthy-ori 3-1 cells transfected with si-control or si-PATZ1. Representative images of scratch wound assay in Nthy-ori 3-1 cells transfected with si-control or si-PATZ1 at 0 h and 16 h after a confluent cell monolayer was scratched (left panel, scale bar = 200 µm). The length of the gap at 100 points was measured for each sample and the average ratio of residual gap to the initial gap is shown in the bar chart (right panel). (C) Chamber migration assay for Nthy-ori 3-1 cells transfected with si-control or si-PATZ1. Representative images of migrating cells stained with crystal violet in Nthy-ori 3-1 cells transfected with si-control or si-PATZ1 at 24 h (left panel, scale bar = 200 µm). The number of migrated cells is shown in the bar chart (right panel). (D) Chamber-invasion assay for Nthy-ori 3-1 cells transfected with si-control or si-PATZ1. The cells that invaded through the transwell chamber coated with collagen type IV were counted as described in Materials and Methods. The absorbance values are shown in the bar chart. (E) The expression of PATZ1, uPA, and MMPs in Nthy-ori 3-1 cells transfected with si-control or si-PATZ1. A representative western blot is shown. SP1 and ß-actin were used as internal loading control for nuclear extract and whole cell lysate, respectively. (F) Activity of uPA in Nthy-ori 3-1 cells transfected with si-control or si-PATZ1. A representative picture of fibrin zymography is shown. Urokinase was used as a positive control and the enzymatic activity was detected at 42 kDa. (G) Activities of MMP2 and MMP9 in Nthy-ori 3-1 cells transfected with si-control or si-PATZ1. A representative picture of gelatin zymography is shown. Degradation of gelatin is detected at approximately 92 kDa (Pro MMP9), 72 kDa (ProMMP2), and 66 kDa (MMP2).
Supplier Page from Abcam for Anti-uPA antibody [EP6274(2)]